FDA PROPOSED PHYSICIAN LABELING REVISIONS WILL BE TESTED WITH 480 MDs: PUBLIC WORKSHOP ON LABELING CHANGES MAY BE CONVENED BY AGENCY THIS SUMMER
Executive Summary
An FDA contractor is slated to conduct a quantitative study of the reaction of 480 health care professionals to new formats of drug labeling. The health care professionals will be given drug labeling mock-ups by National Biosystems and asked about format preferences.
You may also be interested in...
FDA 2004 Reg Agenda Includes CFC Albuterol Phase Out, Final Label Rule
FDA will begin the phase out of CFC-containing albuterol products during 2004, according to HHS' semiannual regulatory agenda published in the Dec. 22 Federal Register
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011